News Headlines Article

FDA OKs insomnia, cancer drugs
San Diego Union-Tribune

The FDA recently approved drugs to treat insomnia, late-stage cervical cancer, skin infections and Gaucher disease.

Belsomra (suvorexant) will be prescribed for people who have trouble falling and staying asleep, a health issue that affects about 30 percent of the general population. says that Belsomra, the first in a new class of sleep medications, will become available to patients late this year or in early 2015.